April 18th 2025
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Ulipristal is Safe and Effective for Uterine Fibroids
February 10th 2012Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size of uterine fibroids.
Read More
The Utility of Magnetic Resonance Imaging (MRI) and How It Is Used to Diagnose Uterine Fibroids
December 7th 2011William Parker, MD discusses the use of MRI in diagnosing and managing uterine fibroids. Dr. Parker's upcoming Clinical Opinion article, “The utility of MRI for the surgical treatment of women with uterine fibroid tumors”, will be published in the American Journal of Obstetrics and Gynecology in 2012.
Read More
Genital Wart Management: A Partnership Between Physician and Patient
With its implications of sexual transmission and potential cervical cancer, a diagnosis of genital warts can be emotionally distressing to patients. Because no single treatment serves every patient, the best approach to selecting a therapeutic option considers the extent of the disease, wart location, and the patient's individual needs.
Read More
A New Contraceptive Option: A Focus on the Transdermal Contraceptive System
And my task for this afternoon is to review for you a new contraceptive option and what I’d like to do first is show you my disclosure statement and then I will go into the first part of discussion, talk about why I think there’s a need for this new contraception option and then go in much greater depth in discussing it.
Read More
Transdermal Contraception: Contraception Patch. Interview with Ronald T. Burkman, MD
“We just heard a presentation about one of the several new devices for contraception and you took part in a lot of research about this Transdermal Patches for contraception.
Read More
think it’s important to start with why we need new. When it’s I think clear for many of our subscribers and many clinicians that the methods that we already have are very effective, that despite having very effective methods, throughout Europe, United States and around the world we are still met with very high rates of unintended pregnancy.
Read More
Oral Contraceptive Linked to Increased Risk for VTE
November 15th 2011Which oral contraceptive is most appropriate for your patient? A new study published in the British Medical Journal may influence your prescribing decision, as researchers have found that certain oral contraceptives are more likely to cause venous thromboembolism (VTE).
Read More
A Different Kind of Success Story
November 13th 2011My PCOS story really began in January of 1993, after discontinuing the use of birth control pills. I was 19 years old when I stopped taking the pill, I had with my high school sweetheart since I was 15 years old, and on the pill since I was 16.
Read More